Common Uses and Adverse Effects of Hyperbaric Oxygen Therapy in a Cohort of Small Animal Patients: A Retrospective Analysis of 2,792 Treatment Sessions

Hyperbaric oxygen therapy (HBOT) is commonly utilized for various human conditions with a low incidence of major adverse effects (0.002–0.035%). Despite growing use in veterinary patients, there remains a paucity of literature describing its use and associated complications. The purpose of this stud...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Christina Montalbano, Caroline Kiorpes, Lindsay Elam, Erin Miscioscia, Justin Shmalberg
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/c739a512a67b475587ddc5f52027d6d8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c739a512a67b475587ddc5f52027d6d8
record_format dspace
spelling oai:doaj.org-article:c739a512a67b475587ddc5f52027d6d82021-12-01T03:11:28ZCommon Uses and Adverse Effects of Hyperbaric Oxygen Therapy in a Cohort of Small Animal Patients: A Retrospective Analysis of 2,792 Treatment Sessions2297-176910.3389/fvets.2021.764002https://doaj.org/article/c739a512a67b475587ddc5f52027d6d82021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fvets.2021.764002/fullhttps://doaj.org/toc/2297-1769Hyperbaric oxygen therapy (HBOT) is commonly utilized for various human conditions with a low incidence of major adverse effects (0.002–0.035%). Despite growing use in veterinary patients, there remains a paucity of literature describing its use and associated complications. The purpose of this study was to report clinical use of HBOT in small animals and identify the rate of major adverse events at a university teaching hospital. Electronic medical records were searched for small animals receiving HBOT between November 2012 and February 2020. Data extracted from the medical records included signalment, treatment indication, and adverse events. Treatment sessions totaled 2,792 in 542 dogs, 24 cats, and 10 pocket pets and exotics. Common indications included neurologic injuries (50.4%), tissue healing (31.4%), control of oomycete infection (5.5%), neoplasia or post-radiation injury (5.4%), and various miscellaneous conditions (7.4%). Observed minor adverse events included agitation in two dogs and vomiting in three dogs. The most common major adverse event was central nervous system (CNS) oxygen toxicity in 19 dogs. Central nervous system oxygen toxicity, manifesting as focal or generalized seizures, occurred in 0.7% of treatment sessions, with increasing age (p = 0.01) and female sex (p = 0.01) identified as risk factors. One dog developed pulmonary edema following HBOT which is a reported adverse event in humans or may have been a manifestation of progression of the dog's underlying disease. No adverse events were noted in cats or other species. In conclusion, HBOT appeared safe across various indications, although oxygen toxicity affecting the CNS was higher than reports in humans. Future prospective, randomized, controlled trials should evaluate specific clinical indications and outcomes.Christina MontalbanoCaroline KiorpesLindsay ElamErin MisciosciaJustin ShmalbergFrontiers Media S.A.articlehyperbaric oxygen therapyintegrative veterinary medicineadverse eventsoxygen toxicityseizuresVeterinary medicineSF600-1100ENFrontiers in Veterinary Science, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic hyperbaric oxygen therapy
integrative veterinary medicine
adverse events
oxygen toxicity
seizures
Veterinary medicine
SF600-1100
spellingShingle hyperbaric oxygen therapy
integrative veterinary medicine
adverse events
oxygen toxicity
seizures
Veterinary medicine
SF600-1100
Christina Montalbano
Caroline Kiorpes
Lindsay Elam
Erin Miscioscia
Justin Shmalberg
Common Uses and Adverse Effects of Hyperbaric Oxygen Therapy in a Cohort of Small Animal Patients: A Retrospective Analysis of 2,792 Treatment Sessions
description Hyperbaric oxygen therapy (HBOT) is commonly utilized for various human conditions with a low incidence of major adverse effects (0.002–0.035%). Despite growing use in veterinary patients, there remains a paucity of literature describing its use and associated complications. The purpose of this study was to report clinical use of HBOT in small animals and identify the rate of major adverse events at a university teaching hospital. Electronic medical records were searched for small animals receiving HBOT between November 2012 and February 2020. Data extracted from the medical records included signalment, treatment indication, and adverse events. Treatment sessions totaled 2,792 in 542 dogs, 24 cats, and 10 pocket pets and exotics. Common indications included neurologic injuries (50.4%), tissue healing (31.4%), control of oomycete infection (5.5%), neoplasia or post-radiation injury (5.4%), and various miscellaneous conditions (7.4%). Observed minor adverse events included agitation in two dogs and vomiting in three dogs. The most common major adverse event was central nervous system (CNS) oxygen toxicity in 19 dogs. Central nervous system oxygen toxicity, manifesting as focal or generalized seizures, occurred in 0.7% of treatment sessions, with increasing age (p = 0.01) and female sex (p = 0.01) identified as risk factors. One dog developed pulmonary edema following HBOT which is a reported adverse event in humans or may have been a manifestation of progression of the dog's underlying disease. No adverse events were noted in cats or other species. In conclusion, HBOT appeared safe across various indications, although oxygen toxicity affecting the CNS was higher than reports in humans. Future prospective, randomized, controlled trials should evaluate specific clinical indications and outcomes.
format article
author Christina Montalbano
Caroline Kiorpes
Lindsay Elam
Erin Miscioscia
Justin Shmalberg
author_facet Christina Montalbano
Caroline Kiorpes
Lindsay Elam
Erin Miscioscia
Justin Shmalberg
author_sort Christina Montalbano
title Common Uses and Adverse Effects of Hyperbaric Oxygen Therapy in a Cohort of Small Animal Patients: A Retrospective Analysis of 2,792 Treatment Sessions
title_short Common Uses and Adverse Effects of Hyperbaric Oxygen Therapy in a Cohort of Small Animal Patients: A Retrospective Analysis of 2,792 Treatment Sessions
title_full Common Uses and Adverse Effects of Hyperbaric Oxygen Therapy in a Cohort of Small Animal Patients: A Retrospective Analysis of 2,792 Treatment Sessions
title_fullStr Common Uses and Adverse Effects of Hyperbaric Oxygen Therapy in a Cohort of Small Animal Patients: A Retrospective Analysis of 2,792 Treatment Sessions
title_full_unstemmed Common Uses and Adverse Effects of Hyperbaric Oxygen Therapy in a Cohort of Small Animal Patients: A Retrospective Analysis of 2,792 Treatment Sessions
title_sort common uses and adverse effects of hyperbaric oxygen therapy in a cohort of small animal patients: a retrospective analysis of 2,792 treatment sessions
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/c739a512a67b475587ddc5f52027d6d8
work_keys_str_mv AT christinamontalbano commonusesandadverseeffectsofhyperbaricoxygentherapyinacohortofsmallanimalpatientsaretrospectiveanalysisof2792treatmentsessions
AT carolinekiorpes commonusesandadverseeffectsofhyperbaricoxygentherapyinacohortofsmallanimalpatientsaretrospectiveanalysisof2792treatmentsessions
AT lindsayelam commonusesandadverseeffectsofhyperbaricoxygentherapyinacohortofsmallanimalpatientsaretrospectiveanalysisof2792treatmentsessions
AT erinmiscioscia commonusesandadverseeffectsofhyperbaricoxygentherapyinacohortofsmallanimalpatientsaretrospectiveanalysisof2792treatmentsessions
AT justinshmalberg commonusesandadverseeffectsofhyperbaricoxygentherapyinacohortofsmallanimalpatientsaretrospectiveanalysisof2792treatmentsessions
_version_ 1718405926474481664